FDA warns websites selling unapproved Botox for cosmetic purposes

By MATTHEW PERRONE
U.S. health regulators on Wednesday sent warning letters to 18 websites selling counterfeit or unapproved versions of Botox and similar injectable drugs commonly used to smooth wrinkles.
Related Articles Shipping delays expected after UPS cargo plane crash Starbucks’ union workers plan strike next week unless company agrees to a contract Judge in Comey case scolds prosecutors as he orders them to produce records from probe Wall Street gains ground amid steady flow of ear